Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma - Tools for choice of radionuclide therapy

Hormone and Metabolic Research

Volumn 44, Issue 5, 2012, Pages 400-404

  Spetz, J ^a   Dalmo, J ^a   Nilsson, O ^b   Wangberg B ^b   Ahlman, H ^b   Forssell Aronsson, E ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

clomipramine; norepinephrine transporter; octreotate; reserpine; somatostatin receptors; VMAT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; CLOMIPRAMINE; PENTETREOTIDE IN 111; PHENOXYBENZAMINE; RESERPINE; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE METASTASIS; CASE REPORT; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG UPTAKE; EXON; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; INCUBATION TIME; LIVER METASTASIS; MEMBRANE BINDING; MUSCLE BIOPSY; PARAGANGLIOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RADIOACTIVITY; TUMOR BIOPSY; TUMOR CELL;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; NEOPLASM METASTASIS; OCTREOTIDE; PHEOCHROMOCYTOMA; RADIOPHARMACEUTICALS; TUMOR CELLS, CULTURED;

EID: 84858706939     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1311603     Document Type: Article

References (32)

1. Ahlman H. Malignant Pheochromocytoma: state of the field with future projections. Ann NY Acad Sci: 2005; 1073 449 464 (Pubitemid 44912040)
2. Chrisoulidou A, Kaltsas G, Ilias I, Grossman A. The diagnosis of malignant pheochromocytoma and paraganglioma. Endocr Relat Cancer: 2007; 14 569 585
3. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul J L, Strompf L, Schlumberger M, Bertagna X, Plouin P F, Jeunemaitre X, Gimenez-Roqueplo A P. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol: 2005; 23 8812 8818 (Pubitemid 46211527)
4. Brouwers F M, Eisenhofer G, Tao J J, Kant J A, Adams K T, Linehan W M, Pacak K. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab: 2006; 91 4505 4509 (Pubitemid 44833431)
5. Wängberg B, Muth A, Khorram-Manesh A, Jansson S, Nilsson O, Forssell-Aronsson E, Tisell L E, Ahlman H. Malignant pheochromocytoma in a population-based study: survival and clinical results. Ann NY Acad Sci: 2006; 1073 512 516 (Pubitemid 44912045)
6. Khoram-Manesh A, Ahlman H, Nilsson O, Friberg P, Odn A, Stenström G, Hansson G, Stenquist O, Wängberg B, Tisell L E, Jansson S. Long-term outcome of a large series of patients surgicallt treated for pheochromocytoma. J Inter Med: 2005; 258 55 66 (Pubitemid 40904933)
7. Grogan R H, Mitmaker E J, Duh Q Y. Changing paradigms in the treatment of malignant pheochromocytoma. Cancer Control: 2011; 18 104 112
8. Forssell-Aronsson E, Schüler E, Ahlman H. Advances in the diagnostic imaging of pheochromocytomas. Reports in Medical Imaging: 2011; 4 1 19 available at http://www.dovepress.com/advances-in-the-diagnostic-imaging-of- pheochromocytomas-a7411
9. Forssell-Aronsson E, Bernhardt P, Wängberg B, Kölby L, Nilsson O, Ahlman H. Aspects on radionuclide therapy in malignant pheochromocytomas. Ann NY Acad Sci: 2006; 1073 498 504 (Pubitemid 44912043)
10. Shulkin B L, Ilias I, Sisson J C, Pacak K. Current trends in functional imaging of pheochromocytomas and paragangliomas. Ann NY Acad Sci: 2006; 1073 374 382 (Pubitemid 44912032)
11. Bönisch H, Brüss M. The noradrenaline transporter of the neuronal plasma membrane. Ann N Y Acad Sci: 1994; 733 193 202
12. Erickson J D, Eiden L E, Hoffman B J. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci USA: 1992; 89 10993 10997
13. Liu Y, Peter D, Roghani A, Schuldiner S, Priv G G, Eisenberg D, Brecha N, Edwards R H. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell: 1992; 70 539 551
14. Henry J P, Botton D, Sagne C, Isambert M F, Desnos C, Blanchard V, Raisman-Vozari R, Krejci E, Massoulie J, Gasnier B. Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules. J Exp Biol: 1994; 196 251 262
15. Jakobsen A M, Andersson P, Saglik G, Andersson E, Kölby L, Erickson J D, Forssell-Aronsson E, Wängberg B, Ahlman H, Nilsson O. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours. J Pathol: 2001; 195 463 472 (Pubitemid 33069672)
16. Kölby L, Bernhardt P, Johanson V, Wängberg B, Muth A, Jansson S, Forssell-Aronsson E, Nilsson O, Ahlman H. Can quantification of VMAT and sstr expression be helpful for planning radionuclide therapy of malignant pheochromocytomas? Ann NY Acad Sci: 2006; 1073 491 497 (Pubitemid 44912042)
17. Kölby L, Bernhardt P, Levin-Jakobsen A M, Wängberg B, Ahlman H, Forssell-Aronsson E, Nilsson O. Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters. Br J Cancer: 2003; 89 1383 1388 (Pubitemid 37368903)
18. Muth A, Abel F, Jansson S, Nilsson O, Ahlman H, Wängberg B. Prevalence of germ-line mutations in patients with PC or abdominal PGL and sporadic presentation: A population-based study in western Sweden. World J Surg Jan 20: 2012; [Epub ahead of print]
19. 111In-DTPA-Phe-1-Octreotide. J Nucl Med: 1995; 36 7 12
20. Arvidsson Y, Bergström A, Arvidsson A, Kristiansson E, Ahlman H, Nilsson O. Hypoxia stimulates CXCR4 signalling in ileal carcinoids. Endocr Relat Cancer: 2010; 17 303 316
21. Mukherjee J J, Kaltsas G A, Islam N, Plowman P N, Foley R, Hikmat J, Britton K E, Jenkins K J, Chew S L, Monson J P, Besser G M, Grossman A B. Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with 131I-meta-iodobenzylguanidine (131I-mIBG). Clin Endocrinol: 2001; 55 47 60 (Pubitemid 34204299)
22. Safford S D, Coleman R E, Gockerman J P, Moore J, Feldman J M, Leight G S Jr, Tyler D S, Olson J A Jr. Iodine-131-metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery: 2003; 134 956 962
23. 131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest: 1997; 20 648 658 (Pubitemid 28056835)
24. Gonias S, Goldsby R, Matthay K K, Hawkins R, Price D, Huberty J, Damon L, Linker C, Sznewajs A, Shiboski S, Fitzgerald P. Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol: 2009; 27 4162 4168
25. 111In-labelled octreotide binding by the somatostatin receptor subtype 2 in neuroendocrine tumours. Br J Surg: 2003; 90 549 554
26. 1-Octreotide. Acta Oncol: 2004; 43 436 442 (Pubitemid 39037091)
27. Cleary S, Brouwers F M, Eisenhofer G, Pacak K, Christie D L, Lipski J, McNeil A R, Phillips J K. Expression of the noradrenaline transporter and phenylethanolamine N-methyltransferase in normal human adrenal gland and phaeochromocytoma. Cell Tiss Res: 2005; 322 443 453 (Pubitemid 41682354)
28. Meco D, Lasorella A, Riccardi A, Servidei T, Mastrangelo R, Riccardi R. Influence of cisplatin and doxorubicin on 125I-meta-iodobenzylguanidine uptake in human neuroblastoma cell lines. Eur J Cancer: 1999; 35 1227 1234 (Pubitemid 29359183)
29. 131I]MIBG and topotecan: A rationale for combination therapy for neuroblastoma. Cancer Lett: 2005; 228 221 227 (Pubitemid 41188445)
30. Zha Q, Wang Y, Fan Y, Zhu M Y. Dexamethasone-induced up-regulation of the human norepinephrine transporter involves the glucocorticoid receptor and increased binding of C/EBP- to the proximal promoter of norepinephrine transporter. J Neurochem: 2011; 119 654 663
31. Kippenberger A G, Palmer D J, Comer A M, Lipski J, Burton L D, Christie D L. Localization of the noradrenaline transporter in rat adrenal medulla and PC12 cells: evidence for its association with secretory granules in PC12 cells. J Neurochem: 1999; 73 1024 1032 (Pubitemid 29395458)
32. Sung B, Lim G, Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci: 2003; 23 2899 2910 (Pubitemid 36418626)